Are there clinical phenotypes of homozygous sickle cell disease?

被引:50
|
作者
Alexander, N
Higgs, D
Dover, G
Serjeant, GR
机构
[1] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England
[2] Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England
[3] Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA
[4] Univ W Indies, MRC Labs Jamaica, Kingston 7, Jamaica
关键词
sickle cell; leg ulcers; painful crisis; clinical phenotypes; polymorphisms;
D O I
10.1111/j.1365-2141.2004.05025.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The distribution of clinical features was examined in subjects with homozygous sickle cell (SS) disease in the Jamaican Cohort Study to determine whether there is evidence of distinct clustering of symptoms or clinical phenotypes. A twofold model yielded groups that could be interpreted as painful crisis or leg ulcer phenotypes and 78% of patients were classified with 95% confidence into one of these. The painful crisis phenotype also manifested higher frequencies of dactylitis, meningitis/septicaemia, acute chest syndrome and stroke. Attempts to define a three-group model were less convincing although 43% of patients could be allocated with 95% confidence. The three-group model essentially divided subjects with the leg ulcer phenotype into subgroups with higher and lower frequencies of painful crisis, dactylitis, meningitis/septicaemia and acute chest syndrome. In the three-group model, the painful crisis phenotype had lower total haemoglobin, fetal haemoglobin, mean cell volume and higher reticulocytes but there was no apparent influence of alpha thalassaemia or beta globin haplotype. Both environmental and genetic factors are likely to contribute to most manifestations of SS disease and the evidence for different clinical phenotypes suggests that a search for associated genetic polymorphisms may provide insights into the mechanisms of clinical variability in SS disease.
引用
收藏
页码:606 / 611
页数:6
相关论文
共 50 条
  • [21] Sickle-resistant sickle cells in patients with homozygous sickle cell disease.
    Miyasaka, E
    Shah, S
    Abdulmalik, O
    Asakura, T
    BLOOD, 2001, 98 (11) : 18B - 18B
  • [22] CLINICAL-EVALUATION OF ANTIPNEUMOCOCCAL VACCINATION IN CHILDREN WITH HOMOZYGOUS SICKLE-CELL DISEASE
    OMANGA, U
    SAFARY, A
    MULEFU, KM
    ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1984, 64 (03): : 283 - 289
  • [23] Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria
    Akinbami A.
    Dosunmu A.
    Adediran A.
    Oshinaike O.
    Adebola P.
    Arogundade O.
    BMC Research Notes, 5 (1)
  • [24] DELAYED MENARCHE IN HOMOZYGOUS SICKLE-CELL DISEASE
    GRAHAM, C
    MAUDE, GH
    SERJEANT, GR
    WEST INDIAN MEDICAL JOURNAL, 1986, 35 (01): : 18 - 22
  • [25] ABDOMINAL COMPLICATIONS IN HOMOZYGOUS SICKLE-CELL DISEASE
    MCCALL, IW
    BRITISH JOURNAL OF RADIOLOGY, 1978, 51 (601): : 71 - 72
  • [26] Homozygous sickle cell disease and cystic fibrosis in an adolescent
    Warwick, AB
    Haver, K
    Rosoff, PM
    PEDIATRIC PULMONOLOGY, 1998, 26 (03) : 224 - 227
  • [27] PRIAPISM AND IMPOTENCE IN HOMOZYGOUS SICKLE-CELL DISEASE
    EMOND, AM
    HOLMAN, R
    HAYES, RJ
    SERJEANT, GR
    ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (11) : 1434 - 1437
  • [28] Cilostazol and blood viscoelasticity in homozygous sickle cell disease
    Lester, D. A.
    Richards, A. A.
    Younger-Coleman, N. O.
    Pepple, D. J.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2014, 71 (04) : 172 - 175
  • [29] THE DEVELOPMENT OF CARDIOMEGALY IN HOMOZYGOUS SICKLE-CELL DISEASE
    STEVENS, MCG
    CROOKS, GW
    SERJEANT, GR
    WEST INDIAN MEDICAL JOURNAL, 1985, 34 (04): : 253 - 256
  • [30] Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease
    Nsiri, B
    Gritli, N
    Bayoudh, F
    Messaoud, T
    Fattoum, S
    Machghoul, S
    HEMATOLOGY AND CELL THERAPY, 1996, 38 (03): : 279 - 284